Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Ivabradine Attenuate Post-revascularisation Microcirculatory Dysfunction in Flow Limiting Coronary Artery Disease?

NCT02507050 is registered in ClinicalTrials.gov with Liverpool Heart and Chest Hospital NHS Foundation Trust as lead sponsor.

NCT NCT02507050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02507050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Ivabradine Attenuate Post-revascularisation Microcirculatory Dysfunction in Flow Limiting Coronary Artery Disease?
Lead sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2016
Completion date
March 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina, coronary artery disease